Experimental CAR-T therapy is providing life-changing results in patients with stiff person syndrome
From Mayo Clinic · · 2 min

The player loads from YouTube only when you click. It uses YouTube's privacy-enhanced mode.
If the video does not play, the owner may have turned off embedding. Watch it on YouTube instead.
Description
A multicenter clinical trial evaluating chimeric antigen receptor-T cell therapy (CAR-T cell therapy) for stiff person syndrome (SPS), a rare autoimmune neurologic disorder, has produced promising results that are already changing lives.
The study, published in Jama Neurology, found evidence of substantial clinical improvement among participants treated with CAR-T cell therapy. Researchers say the findings warrant further investigation. ____________________________________________ FOR THE PUBLIC: More health and medical news on the Mayo Clinic News Network. https://newsnetwork.mayoclinic.org/
FOR THE MEDIA ONLY: To access clean and NAT sound versions of this video on the Mayo Clinic News Network, register at https://newsnetwork.mayoclinic.org/request-account/
Mayo Clinic: https://mayocl.in/3tNMAdF Like Mayo Clinic on Facebook: https://www.facebook.com/MayoClinic Follow Mayo Clinic on Instagram https://www.instagram.com/mayoclinic/ Follow Mayo Clinic on X, formerly Twitter: https://x.com/MayoClinic Follow Mayo Clinic on Threads: https://www.threads.net/@mayoclinic